Are Metabolic Risk Factors and Target Organ Damage More Frequent in Masked Hypertension Than in White Coat Hypertension?

By Yoon Hyun Ju   Ahn Youngkeun   Park Jeong Bae   Park Chang Gyu   Youn Ho Joong   Choi Dong Ju   Shin Joon-Han   Kim Dong-Woon   Rim Se Joong   Bae Jang Ho  

Clinical and Experimental Hypertension, Vol. 32, Iss. 7, 2010-11 ,pp. : 480-485

Informa Healthcare

Access to resources Recommend Favorite

Atherogenesis in White Coat Hypertension

By  

Current Hypertension Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 147-150

Bentham Science Publishers

Access to resources Recommend Favorite

White Coat Hypertension and Carotid Atherosclerosis

By LANDRAY MARTIN J.   SAGAR GIAN   MURRAY SARAH   BEEVERS MICHÈLE   BEEVERS D. GARETH   LIP GREGORY Y. H.  

Blood Pressure, Vol. 8, Iss. 3, 1999-10 ,pp. : 134-140

Informa Healthcare

Access to resources Recommend Favorite

Cardiac Damage in Hypertensive Patients with Inverse White Coat Hypertension. Hospitalet Study

By HERNÁNDEZ DEL-REY RAQUEL   ARMARIO PEDRO   MARTÍN-BARANERA MONTSERRAT   SÁNCHEZ PILAR   CRUZ ALMENDROS MARI   COCA ANTONIO   PARDELL HELIOS  

Blood Pressure, Vol. 12, Iss. 2, 2003-01 ,pp. : 89-96

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic Criteria of White Coat Hypertension (WCH): Consequences for the Implications of WCH for Target Organs

By Pose-Reino A.   Rodríguez-Fernández M.   López-Barreiro L.   Coleman I.-C.   Estévez-Nuñez J. C.   Méndez-Naya I.  

Blood Pressure, Vol. 11, Iss. 3, 2002-05 ,pp. : 144-150

Informa Healthcare

Access to resources Recommend Favorite